Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial (MM03)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2012 by University of Regensburg
Sponsor:
Collaborator:
ClinAssess GmbH
Information provided by (Responsible Party):
Albrecht Reichle, University of Regensburg
ClinicalTrials.gov Identifier:
NCT01010243
First received: November 6, 2009
Last updated: May 29, 2012
Last verified: May 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: October 2016
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)